{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:27:06Z","timestamp":1793276826589,"version":"4.5.0"},"reference-count":173,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jhep.2023.09.031","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T08:16:39Z","timestamp":1699258599000},"page":"155-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?"],"prefix":"10.1016","volume":"80","author":[{"given":"Kim N.","family":"van Munster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyriel Y.","family":"Ponsioen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib1","first-page":"139","article-title":"Beethoven's autopsy revisited: a pathologist sounds a final note","volume":"25","author":"Oiseth","year":"2017","journal-title":"J\u00a0Med Biogr"},{"issue":"8","key":"10.1016\/j.jhep.2023.09.031_bib2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.cub.2023.02.041","article-title":"Genomic analyses of hair from Ludwig van Beethoven","volume":"33","author":"Begg","year":"2023","journal-title":"Curr Biol"},{"key":"10.1016\/j.jhep.2023.09.031_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.151904","article-title":"Beethoven's triad: diarrhoea, deafness and cirrhosis. A plausible solution to the 195-year-old controversy","volume":"58","author":"Allen","year":"2022","journal-title":"Ann Diagn Pathol"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/01.mao.0000178149.36881.df","article-title":"The deafness of Ludwig van Beethoven: an immunopathy","volume":"26","author":"Karmody","year":"2005","journal-title":"Otol Neurotol"},{"issue":"8","key":"10.1016\/j.jhep.2023.09.031_bib5","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/MEG.0000000000000660","article-title":"Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in The Netherlands","volume":"28","author":"de Groof","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib8","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jhep.2023.09.031_bib9","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/liv.14645","article-title":"Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis","volume":"40","author":"Culver","year":"2020","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","article-title":"Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process","volume":"161","author":"Ponsioen","year":"2021","journal-title":"Gastroenterology"},{"issue":"10139","key":"10.1016\/j.jhep.2023.09.031_bib12","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jhep.2023.09.031_bib13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib14","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib15","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.09.031_bib16","series-title":"PSC support patient insights","author":"Support","year":"2020"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2023.09.031_bib18","first-page":"1","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jhep.2023.09.031_bib19","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","article-title":"Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies","volume":"20","author":"Trivedi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhep.2023.09.031_bib21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1478-3231.2008.01726.x","article-title":"Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis","volume":"28","author":"Tanaka","year":"2008","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jhbp.50","article-title":"Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan","volume":"21","author":"Tanaka","year":"2014","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jhep.2023.09.031_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2013.07.005","article-title":"Geoepidemiology of primary sclerosing cholangitis: a critical review","volume":"46","author":"Tanaka","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"10114","key":"10.1016\/j.jhep.2023.09.031_bib24","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broome","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00004836-200110000-00008","article-title":"Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey","volume":"33","author":"Parlak","year":"2001","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00365528209181041","article-title":"Sclerosing cholangitis in ulcerative colitis. A follow-up study","volume":"17","author":"Schrumpf","year":"1982","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365529108996489","article-title":"Prevalence of\u00a0hepatobiliary dysfunction in a regional group of patients with chronic\u00a0inflammatory bowel disease","volume":"26","author":"Wewer","year":"1991","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jhep.2023.09.031_bib30","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1440-1746.1996.tb00286.x","article-title":"Primary sclerosing cholangitis: an experience from India","volume":"11","author":"Kochhar","year":"1996","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.hepres.2004.03.006","article-title":"Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients","volume":"29","author":"Takikawa","year":"2004","journal-title":"Hepatol Res"},{"issue":"7","key":"10.1016\/j.jhep.2023.09.031_bib33","first-page":"685","article-title":"Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"Jorgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib35","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/liv.14159","article-title":"Disease progression in paediatric- and adult-onset sclerosing cholangitis: results from two independent Dutch registries","volume":"39","author":"Joosse","year":"2019","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib36","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cgh.2020.04.055","article-title":"Colorectal dysplasia and cancer in pediatric-onset ulcerative colitis associated with primary sclerosing cholangitis","volume":"19","author":"El-Matary","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib37","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"Electronic address eee, European association for the study of the L. EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2023.09.031_bib40","article-title":"Survey uncovering variations in the management of primary sclerosing cholangitis across Europe","volume":"4","author":"Eliasson","year":"2022","journal-title":"JHEP Rep"},{"issue":"8","key":"10.1016\/j.jhep.2023.09.031_bib41","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/liv.15650","article-title":"Patient-reported quality of care in primary sclerosing cholangitis","volume":"43","author":"Walmsley","year":"2023","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.jhep.2023.09.031_bib42","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.cgh.2019.08.048","article-title":"Primary sclerosing cholangitis in children with inflammatory bowel diseases is associated with milder clinical activity but more frequent subclinical inflammation and growth impairment","volume":"18","author":"Ricciuto","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2023.09.031_bib43","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.dld.2018.06.024","article-title":"Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease","volume":"50","author":"Belle","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2023.09.031_bib44","series-title":"Abstracts of the 13th congress of ECCO \u2013 European Crohn\u2019s and colitis organisation: journal of crohn's and colitis","article-title":"P217 Usefulness of systematic liver biopsy during a surgery for inflammatory bowel disease for the diagnosis of primary sclerosing cholangitis","author":"Miard","year":"2018"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib45","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.13548","article-title":"Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977-2011","volume":"38","author":"Sorensen","year":"2018","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib46","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib48","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","article-title":"Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study","volume":"33","author":"Joo","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00534-010-0319-8","article-title":"Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"18","author":"Sano","year":"2011","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/ibd\/izz209","article-title":"Unique phenotypic characteristics and clinical course in patients with ulcerative colitis and primary sclerosing cholangitis: a multicenter US experience","volume":"26","author":"Wang","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","article-title":"A\u00a0unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease","volume":"6","author":"Halliday","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cgh.2011.11.010","article-title":"Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease","volume":"10","author":"O'Toole","year":"2012","journal-title":"Clin Gastroenterol H"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib53","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/ibd\/izy106","article-title":"The natural history of newly diagnosed ulcerative colitis in patients with concomitant primary sclerosing cholangitis","volume":"24","author":"Khan","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cgh.2017.07.023","article-title":"Patients with ulcerative colitis and primary sclerosing cholangitis frequently have subclinical inflammation in the proximal colon","volume":"16","author":"Krugliak Cleveland","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib55","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ecco-jcc\/jjy170","article-title":"High serum sCD40 and a distinct colonic T cell profile in ulcerative colitis associated with primary sclerosing cholangitis","volume":"13","author":"Lampinen","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/ecco-jcc\/jjx050","article-title":"Th1 and innate lymphoid cells accumulate in primary sclerosing cholangitis-associated inflammatory bowel disease","volume":"11","author":"Gwela","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib57","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2019.05.006","article-title":"Return to sender: lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis","volume":"71","author":"de Krijger","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.09.031_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840935","article-title":"Epigenetic signatures discriminate patients with primary sclerosing cholangitis and ulcerative colitis from patients with ulcerative colitis","volume":"13","author":"de Krijger","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jhep.2023.09.031_bib59","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/01.pas.0000176435.19197.88","article-title":"Pathologic features and clinical significance of \"backwash\" ileitis in ulcerative colitis","volume":"29","author":"Haskell","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.jhep.2023.09.031_bib60","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis","volume":"6","author":"Dignass","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"issue":"22","key":"10.1016\/j.jhep.2023.09.031_bib62","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.3748\/wjg.14.3497","article-title":"Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"14","author":"Sokol","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib63","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ibd.21569","article-title":"Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea","volume":"17","author":"Ye","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib64","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/gut.38.2.234","article-title":"Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis","volume":"38","author":"Penna","year":"1996","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib65","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00384-011-1140-9","article-title":"The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis","volume":"26","author":"Rahman","year":"2011","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib66","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1016\/j.cgh.2021.02.006","article-title":"Primary sclerosing cholangitis-associated pouchitis: a distinct clinical phenotype","volume":"20","author":"Quinn","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib68","first-page":"1404","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broome","year":"1995","journal-title":"Hepatology"},{"issue":"8\u20139","key":"10.1016\/j.jhep.2023.09.031_bib69","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/00365521.2012.685754","article-title":"Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study","volume":"47","author":"Jorgensen","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies","volume":"28","author":"Zheng","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib71","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","article-title":"Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis","volume":"160","author":"Wijnands","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib72","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s12072-021-10214-6","article-title":"Increased risk of cancer in patients with primary sclerosing cholangitis","volume":"15","author":"Lundberg Bave","year":"2021","journal-title":"Hepatol Int"},{"issue":"7","key":"10.1016\/j.jhep.2023.09.031_bib73","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ajg.2015.65","article-title":"Forty-Year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview","volume":"110","author":"Choi","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jhep.2023.09.031_bib74","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/ecco-jcc\/jjac090","article-title":"Increased risk of non-conventional and invisible dysplasias in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"16","author":"Zhang","year":"2022","journal-title":"J\u00a0Crohns Colitis"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib75","doi-asserted-by":"crossref","first-page":"726","DOI":"10.5946\/ce.2022.132","article-title":"Recent advances in surveillance colonoscopy for dysplasia in inflammatory bowel disease","volume":"55","author":"Na","year":"2022","journal-title":"Clin Endosc"},{"issue":"7","key":"10.1016\/j.jhep.2023.09.031_bib76","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cgh.2018.01.023","article-title":"High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease","volume":"16","author":"Shah","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib77","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.31731","article-title":"De novo colorectal and pancreatic cancer in liver-transplant recipients: identifying the higher-risk populations","volume":"74","author":"Nasser-Ghodsi","year":"2021","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jhep.2023.09.031_bib78","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.23741","article-title":"Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"19","author":"Singh","year":"2013","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.jhep.2023.09.031_bib79","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/BF02049156","article-title":"Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1995","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib80","first-page":"279","article-title":"A\u00a0case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease","volume":"92","author":"Riley","year":"1997","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib81","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.cgh.2018.11.002","article-title":"Statin use is associated with improved outcomes of patients with primary sclerosing cholangitis","volume":"17","author":"Stokkeland","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib82","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/apt.17123","article-title":"Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease","volume":"56","author":"Biron","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib83","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MCG.0b013e3181662426","article-title":"A\u00a0double-blind, placebo-controlled, randomized study of\u00a0infliximab in primary sclerosing cholangitis","volume":"42","author":"Hommes","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.jhep.2023.09.031_bib84","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.cgh.2020.02.014","article-title":"Effects of tumor necrosis factor antagonists in patients with primary sclerosing cholangitis","volume":"18","author":"Hedin","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib85","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/apt.14829","article-title":"Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease","volume":"48","author":"Tse","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jhep.2023.09.031_bib86","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/ecco-jcc\/jjz088","article-title":"Vedolizumab therapy is ineffective for primary sclerosing cholangitis in patients with inflammatory bowel disease: a GETAID multicentre cohort study","volume":"13","author":"Caron","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.jhep.2023.09.031_bib87","article-title":"Colectomy in ulcerative colitis does not prevent development of primary sclerosing cholangitis","volume":"10","author":"Bave","year":"2022","journal-title":"United Eur Gastroenterol J"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/apt.14393","article-title":"Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients","volume":"47","author":"Nordenvall","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.09.031_bib89","article-title":"Proctocolectomy with permanent ileostomy is associated with better transplant-free survival in patients with primary sclerosing cholangitis: a retrospective cohort study","volume":"10","author":"Mol","year":"2022","journal-title":"United Eur Gastroenterol J"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib90","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2036.2012.05067.x","article-title":"The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis","volume":"35","author":"Navaneethan","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib91","first-page":"A361","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"130","author":"Verdonk","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib92","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib93","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ibd.20087","article-title":"Effects of different immunosuppressive regimens on regulatory T-cells in noninflamed colon of liver transplant recipients","volume":"13","author":"Verdonk","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib94","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"Jorgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib95","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2023.09.031_bib96","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ibd\/izz325","article-title":"Activity of inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis predicts poorer clinical outcomes","volume":"26","author":"Peverelle","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib97","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib98","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","article-title":"The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis","volume":"33","author":"Joshi","year":"2013","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib99","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2017.06.027","article-title":"Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis","volume":"67","author":"Trivedi","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib101","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib102","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.14828","article-title":"The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis","volume":"48","author":"Trivedi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.jhep.2023.09.031_bib103","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s10620-012-2165-9","article-title":"A\u00a0shift from colon- to ileum-predominant bacteria in ileal-pouch feces following total proctocolectomy","volume":"57","author":"Hinata","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib104","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/apt.14454","article-title":"Systematic review: ileoanal pouch microbiota in health and disease","volume":"47","author":"Segal","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib106","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib107","first-page":"16","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation - the Hungarian experience","volume":"6","author":"Gelley","year":"2014","journal-title":"Interv Med Appl Sci"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib108","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","article-title":"Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study","volume":"53","author":"Lindstrom","year":"2018","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib109","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2023.09.031_bib110","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib111","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"issue":"2\u20133","key":"10.1016\/j.jhep.2023.09.031_bib112","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12016-014-8417-z","article-title":"Genetics in PSC: what do the \"risk genes\" teach us?","volume":"48","author":"Folseraas","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"10.1016\/j.jhep.2023.09.031_bib113","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib114","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/apt.17256","article-title":"A\u00a0prospective pilot study of a gluten-free diet for primary sclerosing cholangitis and associated colitis","volume":"57","author":"Liwinski","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/apt.17326","article-title":"Editorial: dietary interventions to understand and treat primary sclerosing cholangitis-is gluten-free diet a starting point?","volume":"57","author":"Hov","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib116","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/ecco-jcc\/jjaa223","article-title":"Genetic risk scores identify genetic aetiology of inflammatory bowel disease phenotypes","volume":"15","author":"Voskuil","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib117","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41467-023-36678-8","article-title":"Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis","volume":"14","author":"Han","year":"2023","journal-title":"Nat Commun"},{"issue":"582","key":"10.1016\/j.jhep.2023.09.031_bib118","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb0036","article-title":"A\u00a0heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis","volume":"13","author":"Jiang","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2023.09.031_bib119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4615-4143-1_2","article-title":"Bacterial translocation from the gastrointestinal tract","volume":"473","author":"Berg","year":"1999","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib120","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00006231-200109000-00009","article-title":"(51)CrEDTA colonic permeability and therapy response in patients with ulcerative colitis","volume":"22","author":"Arslan","year":"2001","journal-title":"Nucl Med Commun"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib121","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.34.4.509","article-title":"Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis","volume":"34","author":"Almer","year":"1993","journal-title":"Gut"},{"issue":"7112","key":"10.1016\/j.jhep.2023.09.031_bib122","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0140-6736(59)90098-4","article-title":"The liver in ulcerative\u00a0colitis; treatment of pericholangitis with tetracycline","volume":"2","author":"Rankin","year":"1959","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib123","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"Farkkila","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib124","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0039-1688501","article-title":"Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis","volume":"39","author":"Shah","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib125","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/00365520510023288","article-title":"Intestinal permeability and bacterial growth of the small bowel in patients\u00a0with primary sclerosing cholangitis","volume":"40","author":"Bjornsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib126","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/liv.13979","article-title":"Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis","volume":"39","author":"Dhillon","year":"2019","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.jhep.2023.09.031_bib127","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/liv.14153","article-title":"The gut microbial influence on cholestatic liver disease","volume":"39","author":"Kummen","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib128","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ecco-jcc\/jju023","article-title":"The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II","volume":"9","author":"Rossen","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib129","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/gutjnl-2020-323565","article-title":"Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"issue":"21","key":"10.1016\/j.jhep.2023.09.031_bib130","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","article-title":"Gut microbiome in primary sclerosing cholangitis: a review","volume":"26","author":"Little","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jhep.2023.09.031_bib131","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib132","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib133","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC-IBD is distinct to that of IBD","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.jhep.2023.09.031_bib134","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ismej.2017.44","article-title":"Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation","volume":"11","author":"Fuentes","year":"2017","journal-title":"ISME J"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib135","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00129-19","article-title":"State of the art in the culture of the human microbiota: new interests and strategies","volume":"34","author":"Tidjani Alou","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"7961","key":"10.1016\/j.jhep.2023.09.031_bib136","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41586-023-05989-7","article-title":"Profiling the human intestinal environment under physiological conditions","volume":"617","author":"Shalon","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib137","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat Microbiol"},{"issue":"8","key":"10.1016\/j.jhep.2023.09.031_bib138","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/gutjnl-2018-316670","article-title":"Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis","volume":"68","author":"Liao","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.jhep.2023.09.031_bib139","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.14309\/ajg.0000000000000317","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: the next steps in this promising story","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis","volume":"69","author":"Lemoinne","year":"2020","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jhep.2023.09.031_bib141","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/gutjnl-2019-320008","article-title":"Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species","volume":"69","author":"Ruhlemann","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.09.031_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.829525","article-title":"The emerging role of bile acids in the pathogenesis of inflammatory bowel disease","volume":"13","author":"Thomas","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib143","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"issue":"7785","key":"10.1016\/j.jhep.2023.09.031_bib144","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites\u00a0control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jhep.2023.09.031_bib145","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ecco-jcc\/jjaa021","article-title":"A\u00a0pilot integrative analysis of colonic gene expression, gut microbiota, and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways","volume":"14","author":"Quraishi","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"issue":"9","key":"10.1016\/j.jhep.2023.09.031_bib146","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","article-title":"Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling","volume":"3","author":"Schneider","year":"2021","journal-title":"Nat Metab"},{"issue":"4","key":"10.1016\/j.jhep.2023.09.031_bib147","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib148","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A\u00a0randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2023.09.031_bib149","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.145.10.3247","article-title":"Differential expression of homing-associated adhesion molecules by T cell subsets in man","volume":"145","author":"Picker","year":"1990","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib150","first-page":"97","article-title":"Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue","volume":"151","author":"Briskin","year":"1997","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.jhep.2023.09.031_bib151","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00042737-199907000-00015","article-title":"Immunohistochemical analysis of inflammation in primary sclerosing cholangitis","volume":"11","author":"Ponsioen","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(19)40013-9","article-title":"Analysis of liver infiltrating lymphocytes in primary sclerosing cholangitis by surface antigen and single cell RNAseq","volume":"156","author":"Lynch","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib153","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jhep.2001.24231","article-title":"MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)","volume":"33","author":"Grant","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib154","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.32193","article-title":"Aberrant hepatic trafficking of gut-derived T cells is not specific to primary sclerosing cholangitis","volume":"75","author":"Graham","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2023.09.031_bib155","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jhep.2012.07.008","article-title":"CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver","volume":"57","author":"Oo","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib156","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhep.2016.09.002","article-title":"Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease","volume":"66","author":"Henriksen","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2023.09.031_bib157","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.24085","article-title":"Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity","volume":"53","author":"Liaskou","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib158","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gutjnl-2016-312354","article-title":"Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner","volume":"67","author":"Trivedi","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.09.031_bib159","doi-asserted-by":"crossref","DOI":"10.3310\/ZPNF4670","article-title":"Monoclonal antibody BTT1023 targeting vascular adhesion protein 1 for treating primary sclerosing cholangitis: BUTEO single-arm Phase II trial","author":"Arndtz","year":"2022","journal-title":"Efficacy and mechanism evaluation"},{"issue":"1","key":"10.1016\/j.jhep.2023.09.031_bib160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cgh.2019.05.013","article-title":"Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases","volume":"18","author":"Lynch","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.09.031_bib161","article-title":"Primary stricture of the common bile duct (non-malignant)","volume":"13","author":"F","year":"1931","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib162","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archsurg.1958.01290030139016","article-title":"Primary sclerosing cholangitis; review and report of six cases","volume":"77","author":"Schwartz","year":"1958","journal-title":"AMA Arch Surg"},{"key":"10.1016\/j.jhep.2023.09.031_bib163","unstructured":"Dorland. Dorland's Illustrated medical Dictionary2019."},{"issue":"Suppl 2","key":"10.1016\/j.jhep.2023.09.031_bib164","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000440823","article-title":"Diagnosis, differential diagnosis, and epidemiology of primary sclerosing cholangitis","volume":"33","author":"Ponsioen","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2023.09.031_bib165","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s00535-022-01914-3","article-title":"Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis","volume":"57","author":"Arizumi","year":"2022","journal-title":"J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jhep.2023.09.031_bib166","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib167","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s005350300053","article-title":"Efficacy of bezafibrate in a patient with primary sclerosing cholangitis","volume":"38","author":"Kurihara","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"issue":"7","key":"10.1016\/j.jhep.2023.09.031_bib168","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00535-010-0204-x","article-title":"Bezafibrate for the treatment of primary sclerosing cholangitis","volume":"45","author":"Mizuno","year":"2010","journal-title":"J\u00a0Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib169","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinre.2018.06.009","article-title":"Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience","volume":"42","author":"Lemoinne","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"6","key":"10.1016\/j.jhep.2023.09.031_bib170","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/cpt.1930","article-title":"Fenofibrate improves liver function and reduces the toxicity of the bile acid pool in patients with primary biliary cholangitis and primary sclerosing cholangitis who are partial responders to ursodiol","volume":"108","author":"Ghonem","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib171","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2020.10.001","article-title":"Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double-blind, randomized, placebo-controlled trial","volume":"160","author":"de Vries","year":"2021","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jhep.2023.09.031_bib172","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.dld.2018.07.043","article-title":"Should we set-up routine screening for primary sclerosing cholangitis in all IBD patients?","volume":"50","author":"Bouguen","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.jhep.2023.09.031_bib173","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","article-title":"The microbiota and the gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Hov","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823051589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823051589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:14:16Z","timestamp":1774314856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823051589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0168827823051589"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.09.031","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}